TCOT
AKRO

Trust Company of Toledo’s Akero Therapeutics AKRO Stock Holding History

Trust Company of Toledo’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-50
Closed -$2.37K – 773
2025
Q3 		$2.37K Hold
50
– – ﹤0.01% 714
2025
Q2 		$2.67K Buy
+50
New +$2.27K ﹤0.01% 706

Other funds holding AKRO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Trust Company of Toledo's AKRO Position: Q4 2025 in Review

Trust Company of Toledo sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 50 shares — an estimated $2.37K sold.

Trust Company of Toledo first reported a position in AKRO in Q2 2025 and held it in 2 quarters. The position peaked at $2.67K in Q2 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

  • Trust Company of Toledo reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Trust Company of Toledo sold 50 Akero Therapeutics shares in Q4 2025, an estimated $2.37K.
  • Trust Company of Toledo first reported a position in Akero Therapeutics in Q2 2025 and held it in 2 quarters.
  • Trust Company of Toledo's Akero Therapeutics position peaked at $2.67K in Q2 2025.
  • 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Trust Company of Toledo's 13F filing for Q4 2025, filed 20 Jan 2026.